Trial intelligence / Profile preview

Impact of chronological and demographic factors on intraoperative anesthetic dosing

2008-008193-31Phase 3Active

Sponsor
Hôpital Foch
Start
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of propofol, sponsored by Hôpital Foch. Primary endpoint: Propofol dose by chronological and demographic factors. Started Feb 2009; status: active.

02

Drugs

propofol

Beyond the preview

Go deeper on 2008-008193-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008193-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call